AVXL

AVXL R&D Expense Growth

-10.15%Fiscal year

Period ending:

AVXL FY R&D Growth (YoY)%
AVXL FY R&D Growth (YoY)256.46%-127.18%
2004-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

AVXL r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 22 observations from Sep 30, 2004 to Sep 30, 2025.

Anavex Life Sciences Corp R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-10.1487%
-4.2981%
15.2996%
14.9527%
30.7248%
13.3478%
66.8139%
25.0404%
47.1139%
219.3286%
210.1791%
177.5832%
-90.058%
2.1785%
-4.821%
27.528%
44.6313%
54.1612%
0%
0%
0%
0%

Compare r&d expense growth

All AVXL financial metrics · AVXL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.